Feng Wang

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Huazhong University of Science and Technology(Current)

Feng Wang is an author at Huazhong University of Science and Technology specializing in life sciences, immunology, and colorectal cancer neoadjuvant therapy.

Publications per year

2021–2024

Publications

Neoadjuvant treatment of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) in patients with microsatellite instability-high/mismatch repair-deficient colorectal cancer: Results from a randomized, open-labeled, phase Ib study.

Rui‐Hua Xu, Feng Wang, Gong Chen et al. · Journal of Clinical Oncology · 2024 · 19 citations

Life Sciences, Immunology, Oncology +17

Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients

Qing Lei, Caizheng Yu, Yang Li et al. · Journal of Advanced Research · 2021 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–2 of 2